☆ 4.7 Editorial Material

Parkinson disease(s) Is Parkin disease a distinct clinical entity?

NEUROLOGY (2009)

Journal

NEUROLOGY

Volume 72, Issue 2, Pages 106-107

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1212/01.wnl.0000333666.65522.8d

Keywords

-

Categories

Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Agriculture, Multidisciplinary

Rotenone-Induced Neurodegeneration Is Enabled by a p38-Parkin-ROS Signaling Feedback Loop

Jialong Chen, Mingque Li, Xueqiong Zhou, Ailun Xie, Ziwei Cai, Chunlai Fu, Yongming Peng, He Zhang, Linhua Liu

Summary: The study revealed a novel feedback mechanism of p38-Parkin-ROS regulating rotenone-induced Parkinson's disease. Both p38 activation and Parkin inactivation contribute to the disruption of Parkin-mediated mitophagy, leading to increased reactive oxygen species (ROS) production. Inhibiting p38 and enhancing Parkin activity can reduce ROS levels and restore cell death and mitochondrial function in rotenone-induced PD models.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Add to Collection

Article Neurosciences

A genetic analysis of Chinese patients with early-onset Parkinson? s disease

Qi Liu, Bin Jiang, Min Zou, Zi-Wen Yu, Jing Wang, Chu-Chuan Xu, Si-Ning Lin, Kun-Mu Zheng, Nai-An Xiao, Min Bi, Jian-Peng Li

Summary: This study investigated the genetic spectrum and clinical phenotypic spectrum of EOPD patients in Chinese population. The most common causative gene was found to be PLA2G6, and detailed clinical features were presented.

NEUROSCIENCE LETTERS (2022)

Add to Collection

Review Multidisciplinary Sciences

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer?s and Parkinson?s disease

Abolaji Samson Olagunju, Foysal Ahammad, Abiola Adeyanju Alagbe, Titilayomi Ayomide Otenaike, John Oluwafemi Teibo, Farhan Mohammad, Ahad Amer Alsaiari, Olabode Omotoso, Md Enamul Kabir Talukder

Summary: Mitochondrial dysfunction plays a crucial role in various neurodegenerative diseases. Changes in mitochondrial homeostasis are associated with the onset of Alzheimer's and Parkinson's diseases. Early mitochondrial dysfunctions may contribute to the progression of neuropathological processes.

HELIYON (2023)

Add to Collection

Article Cell Biology

Basal activity of PINK1 and PRKN in cell models and rodent brain

Jens O. Watzlawik, Fabienne C. Fiesel, Gabriella Fiorino, Bernardo A. Bustillos, Zahra Baninameh, Briana N. Markham, Xu Hou, Caleb S. Hayes, Jenny M. Bredenberg, Nicholas W. Kurchaba, Dominika Fricova, Joanna Siuda, Zbigniew K. Wszolek, Sachiko Noda, Shigeto Sato, Nobutaka Hattori, Asheeta A. Prasad, Deniz Kirik, Howard S. Fox, Kelly L. Stauch, Matthew S. Goldberg, Wolfdieter Springer

Summary: This study investigates the basal activation levels of the PINK1-PRKN signaling pathway in vivo using rodent samples, patient-derived cells, and isogenic neurons. The findings highlight the age-dependent, brain region-specific, and cell type-specific effects of PINK1-PRKN signaling, which have significant implications for improving diagnosis, prognosis, and patient stratification in Parkinson's disease.

AUTOPHAGY (2023)

Add to Collection

Article Cell Biology

Substitution of PINK1 Gly411 modulates substrate receptivity and turnover

Fabienne C. Fiesel, Dominika Fricova, Caleb S. Hayes, Mathew A. Coban, Roman Hudec, Jenny M. Bredenberg, Benjamin J. Broadway, Briana N. Markham, Tingxiang Yan, Paige K. Boneski, Gabriella Fiorino, Jens O. Watzlawik, Xu Hou, Arthur M. McCarty, Laura J. Lewis-Tuffin, Jun Zhong, Benjamin J. Madden, Alban Ordureau, Heeseon An, Andreas Puschmann, Zbigniew K. Wszolek, Owen A. Ross, J. Wade Harper, Thomas R. Caulfield, Wolfdieter Springer

Summary: This study investigates the impact of single nucleotide variants in the activation loop of the PINK1 kinase on its enzymatic function. The G411A variant of PINK1 is found to significantly enhance Ub phosphorylation and promote PRKN activation and mitophagy, leading to increased neuronal viability under mitochondrial stress. The mechanism involves the stabilization of PINK1's kinase fold and a change in Ub conformation. These findings suggest that the G411A variant could have therapeutic potential for neuroprotection.

AUTOPHAGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease

Esha Sircar, Sristi Raj Rai, Mark A. Wilson, Michael G. Schlossmacher, Rajib Sengupta

Summary: Parkinson's disease is a rapidly growing neurodegenerative disorder with a strong genetic component. Aberrant S-nitrosylation of proteins like Parkin, DJ-1, and PINK1 may contribute to the pathogenesis of PD, emphasizing the importance of this post-translational modification in neuronal health.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Add to Collection

Article Respiratory System

Fungal bronchitis is a distinct clinical entity which is responsive to antifungal therapy

Leyla Pur Ozyigit, Will Monteiro, Eva-Maria Rick, Jack Satchwell, Catherine Helen Pashley, Andrew John Wardlaw

Summary: Most patients with fungal bronchitis caused by Aspergillus fumigatus and Candida spp. showed clinical improvement in lung function after antifungal therapy, suggesting that fungal bronchitis is a distinct clinical entity that is responsive to treatment.

CHRONIC RESPIRATORY DISEASE (2021)

Add to Collection

Article Multidisciplinary Sciences

Diffusion tensor imaging techniques show that parkin gene S/N167 polymorphism is responsible for extensive brain white matter damage in patients with Parkinson's disease

Jinqiu Yu, Jinying Shi, Lina Chen, Yingqing Wang, Guoen Cai, Xiaochun Chen, Weiming Hong, Qinyong Ye

Summary: The influence of disease and genetic factors on white matter microstructure in patients with PD was explored using ROI and DTT methods. Significant differences were found between PD-G/G and PD-G/A groups. Microstructural changes in the left globus pallidus and left substantia nigra were correlated with cognitive function.

HELIYON (2023)

Add to Collection

Article Clinical Neurology

Disease Progression in Patients with Parkin-Related Parkinson's Disease in a Longitudinal Cohort

Yi-Min Sun, Hui-Ling Yu, Xin-Yue Zhou, Wei-Xi Xiong, Su-Shan Luo, Chen Chen, Feng-Tao Liu, Jue Zhao, Yi-Lin Tang, Xiao-Niu Liang, Yu-Jie Yang, Bo Shen, Yan Shen, Wen-Bo Yu, Zheng-Tong Ding, Yu An, Jian-Jun Wu, Jian Wang

Summary: The study found that patients with Parkin-EOPD showed a slower deterioration of motor symptoms and better spatial processing ability compared to genetically undefined EOPD patients. Subtyping based on genetic features may help predict Parkinson's disease progression.

MOVEMENT DISORDERS (2021)

Add to Collection

Article Cell Biology

PRKN/parkin-mediated mitophagy is induced by the probiotics Saccharomyces boulardii and Lactococcus lactis

Peter John Hawrysh, Jinghua Gao, Stephanie Tan, Amy Oh, Justin Nodwell, Thomas A. Tompkins, G. Angus McQuibban

Summary: This study found that two probiotics, Saccharomyces boulardii and Lactococcus lactis, can promote mitophagy, leading to improved symptoms in patients with Parkinson's disease. The study also identified a compound called methyl-isoquinoline-6-carboxylate that can mimic the effects of probiotics and restore damaged mitochondria, resulting in restored motor function.

AUTOPHAGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting Deubiquitinating Enzymes (DUBs) That Regulate Mitophagy via Direct or Indirect Interaction with Parkin

Eliona Tsefou, Robin Ketteler

Summary: Quality control of mitochondria is crucial for cell survival, and defects can lead to severe diseases. Mitophagy plays a key role in removing damaged mitochondria and enhancing mitophagy has the potential to improve cell survival, neuronal function, and lifespan. Deubiquitinating enzymes are important regulators of mitophagy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Cell Biology

Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples

Jens O. Watzlawik, Xu Hou, Dominika Truban, Chloe Ramnarine, Sandeep K. Barodia, Tania F. Gendron, Michael G. Heckman, Michael DeTure, Joanna Siuda, Zbigniew K. Wszolek, Clemens R. Scherzer, Owen A. Ross, Guojun Bu, Dennis W. Dickson, Matthew S. Goldberg, Fabienne C. Fiesel, Wolfdieter Springer

Summary: Mitochondrial dysfunction is an early event in neurodegenerative disorders like Parkinson's and Alzheimer's disease. Researchers developed a sensitive ELISA tool to measure mitophagy levels and found that the PINK1-PRKN mitophagy pathway is actively involved in both mice and humans under various physiological and pathological conditions.

AUTOPHAGY (2021)

Add to Collection

Article Surgery

Postpancreatectomy Acute Pancreatitis After Pancreaticoduodenectomy A Distinct Clinical Entity

Haoda Chen, Chao Wang, Ziyun Shen, Weishen Wang, Yuanchi Weng, Xiayang Ying, Xiaxing Deng, Baiyong Shen

Summary: This study aimed to characterize postpancreatectomy acute pancreatitis (PPAP) after pancreaticoduodenectomy (PD) in a high-volume center. The results showed that PPAP had a high incidence rate and was associated with postoperative pancreatic fistula, major complications, and biliary leak. Some cases of PPAP presented as an inflammatory process in the early postoperative period, but could also lead to necrotizing pancreatitis or other severe clinical scenarios.

ANNALS OF SURGERY (2023)

Add to Collection

Article Behavioral Sciences

Is NORSE a meaningful clinical entity?

Nicolas Gaspard, Simon Shorvon

Summary: This article summarizes the arguments for and against the proposition that 'NORSE is a meaningful clinical entity' debated at the 8th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. It briefly presents the two sides of the argument. This article is published as part of the special issue of Epilepsy & Behavior, which includes the proceedings of the 8th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. (c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).

EPILEPSY & BEHAVIOR (2023)

Add to Collection

Article Oncology

Lichenoid dysplasia is not a distinct pathological entity

Camile S. Farah, Simon Fox, Kate Shearston, Luke Newman, Sharon Babic, Michael Vacher

Summary: The study found that Oral Lichenoid Dysplasia (OLD) shares molecular and immunophenotypic similarities with Oral Lichen Planus (OLP) and is distinct from Oral Epithelial Dysplasia (OED). It is recommended that OLD not be considered a distinct pathological entity, and dysplasia should be excluded in the diagnosis of OLP.

ORAL ONCOLOGY (2021)

Add to Collection

Article Clinical Neurology

Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset

Joanne Trinh, Theresa Luth, Susen Schaake, Bjorn-Hergen Laabs, Kathleen Schlueter, Joshua Lass, Jelena Pozojevic, Ronnie Tse, Inke Koenig, Roland Dominic Jamora, Raymond L. Rosales, Norbert Brueggemann, Gerard Saranza, Cid Czarina E. Diesta, Frank J. Kaiser, Christel Depienne, Christopher E. Pearson, Ana Westenberger, Christine Klein

Summary: By sequencing the genomes of XDP patients, researchers have discovered various mutations within the repetitive sequence SINE-VNTR-Alu(AGAGGG)(n), which may act as modifiers of disease expression in XDP.

BRAIN (2023)

Add to Collection

Article Genetics & Heredity

MRM2 variants in families with complex dystonic syndromes: evidence for phenotypic heterogeneity

Anum Shafique, Beenish Arif, Mary Lynn Chu, Ellen Moran, Tooba Hussain, Francisca Millan Zamora, Elizabeth Wohler, Nara Sobreira, Christine Klein, Katja Lohmann, Sadaf Naz

Summary: This study investigated patients with dystonic or involuntary movement disorders in two families. Genetic analyses revealed mutations in the MRM2 gene that were associated with the phenotypes.

JOURNAL OF MEDICAL GENETICS (2023)

Add to Collection

Article Clinical Neurology

Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism

Henrike Hanssen, Cid C. E. Diesta, Marcus Heldmann, Jackson Dy, Jeffrey Tantianpact, Julia Steinhardt, Rosanna Sauza, Hans T. S. Manalo, Andreas Sprenger, Charles Jourdan Reyes, Raphael Tuazon, Bjoern-Hergen Laabs, Aloysius Domingo, Raymond L. Rosales, Christine Klein, Thomas F. Muente, Ana Westenberger, Jean Q. Oropilla, Norbert Brueggemann

Summary: In this study, it was found that X-linked dystonia-parkinsonism has basal ganglia atrophy and iron accumulation before the clinical onset. These findings highlight the potential of early diagnosis and the importance of understanding the prodromal phase of the disease.

ANNALS OF NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease

Joanne Trinh, Andrew A. Hicks, Inke R. Koenig, Sylvie Delcambre, Theresa Lueth, Susen Schaake, Kobi Wasner, Jenny Ghelfi, Max Borsche, Carles Vilarino-Gueell, Faycel Hentati, Elisabeth L. Germer, Peter Bauer, Masashi Takanashi, Vladimir Kostic, Anthony E. Lang, Norbert Brueggemann, Peter P. Pramstaller, Irene Pichler, Alex Rajput, Nobutaka Hattori, Matthew J. Farrer, Katja Lohmann, Hansi Weissensteiner, Patrick May, Christine Klein, Anne Gruenewald

Summary: Trinh et al. found that PINK1/PRKN mutations increase the risk of mitochondrial DNA variant accumulation in a dose- and disease-dependent manner. Monoallelic mutation carriers can be distinguished by the level of heteroplasmic mtDNA variants. Biallelic mutations in PINK1/PRKN lead to recessive Parkinson's disease.

BRAIN (2023)

Add to Collection

Article Clinical Neurology

In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN-Related Parkinson's Disease

Max Borsche, Andre Maertens, Philipp Hoermann, Theresa Brueckmann, Katja Lohmann, Sinem Tunc, Christine Klein, Karsten Hiller, Alexander Balck

Summary: This study investigates the differences in glucose metabolism between Parkinson's disease (PD) patients and healthy controls using advanced biochemical methods. The results show that glucose production pathways differ between idiopathic and PRKN mutation carriers, and are associated with diabetes. This study provides the first in vivo evidence for alterations in glucose metabolism in idiopathic PD.

MOVEMENT DISORDERS (2023)

Add to Collection

Review Clinical Neurology

Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review

Malco Rossi, Moath Hamed, Jon Rodriguez-Antiguedad, Mario Cornejo-Olivas, Marianthi Breza, Katja Lohmann, Christine Klein, Rajasumi Rajalingam, Connie Marras, Bart P. van de Warrenburg

Summary: This article systematically reviewed the genotype-phenotype relationships and reevaluated the pathological range of repeat expansions in ATX-TBP. The study proposed new cutoff values for reduced penetrance (41-45 expanded repeats) and full penetrance (46-66 expanded repeats), which have important diagnostic and counseling implications and may guide future clinical trial protocols.

MOVEMENT DISORDERS (2023)

Add to Collection

Article Clinical Neurology

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

Eva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Suzanne Lesage, Christelle Tesson, Marie Vidailhet, Isabel Wurster, Faycel Hentati, Anat Mirelman, Nir Giladi, Karen Marder, Cheryl Waters, Stanley Fahn, Meike Kasten, Norbert Bruggemann, Max Borsche, Tatiana Foroud, Eduardo Tolosa, Alicia Garrido, Grazia Annesi, Monica Gagliardi, Maria Bozi, Leonidas Stefanis, Joaquim J. Ferreira, Leonor Correia Guedes, Micol Avenali, Simona Petrucci, Lorraine Clark, Ekaterina Y. Fedotova, Natalya Y. Abramycheva, Victoria Alvarez, Manuel Menendez-Gonzalez, Silvia Jesus Maestre, Pilar Gomez-Garre, Pablo Mir, Andrea Carmine Belin, Caroline Ran, Chin-Hsien Lin, Ming-Che Kuo, David Crosiers, Zbigniew K. Wszolek, Owen A. Ross, Joseph Jankovic, Kenya Nishioka, Manabu Funayama, Jordi Clarimon, Caroline H. Williams-Gray, Marta Camacho, Mario Cornejo-Olivas, Luis Torres-Ramirez, Yih-Ru Wu, Guey-Jen Lee-Chen, Ana Morgadinho, Teeratorn Pulkes, Pichet Termsarasab, Daniela Berg, Gregor Kuhlenbaumer, Andrea A. Kuhn, Friederike Borngraeber, Giuseppe de Michele, Anna De Rosa, Alexander Zimprich, Andreas Puschmann, George D. Mellick, Jolanta Dorszewska, Jonathan Carr, Rosangela Ferese, Stefano Gambardella, Bruce Chase, Katerina Markopoulou, Wataru Satake, Tatsushi Toda, Malco Rossi, Marcelo Merello, Timothy Lynch, Diana A. Olszewska, Shen-Yang Lim, Azlina Ahmad-Annuar, Ai Huey Tan, Bashayer Al-Mubarak, Hasmet Hanagasi, Dariusz Koziorowski, Sibel Ertan, Gencer Genc, Patricia de Carvalho Aguiar, Melinda Barkhuizen, Marcia M. G. Pimentel, Rachel Saunders-Pullman, Bart van de Warrenburg, Susan Bressman, Mathias Toft, Silke Appel-Cresswell, Anthony E. Lang, Matej Skorvanek, Agnita J. W. Boon, Rejko Kruger, Esther M. Sammler, Vitor Tumas, Bao-Rong Zhang, Gaetan Garraux, Sun Ju Chung, Yun Joong Kim, Juliane Winkelmann, Carolyn M. Sue, Eng-King Tan, Joana Damasio, Peter Klivenyi, Vladimir S. Kostic, David Arkadir, Mika Martikainen, Vanderci Borges, Jens Michael Hertz, Laura Brighina, Mariana Spitz, Oksana Suchowersky, Olaf Riess, Parimal Das, Brit Mollenhauer, Emilia M. Gatto, Maria Skaalum Petersen, Nobutaka Hattori, Ruey-Meei Wu, Sergey N. Illarioshkin, Enza Maria Valente, Jan O. Aasly, Anna Aasly, Roy N. Alcalay, Avner Thaler, Matthew J. Farrer, Kathrin Brockmann, Jean-Christophe Corvol, Christine Klein

Summary: Through a worldwide online survey, we established an international cohort of individuals with PD-linked variants, providing harmonized and quality-controlled clinical and genetic data for each participant and promoting collaboration among researchers in the field of monogenic PD.

MOVEMENT DISORDERS (2023)

Add to Collection

Letter Clinical Neurology

MDSGene: Extending the List of Isolated Dystonia Genes by VPS16, EIF2AK2, and AOPEP

Mirja Thomsen, Lara M. Lange, Christine Klein, Katja Lohmann

MOVEMENT DISORDERS (2023)

Add to Collection

Letter Clinical Neurology

Frequency of non-motor symptoms in Parkinson?s disease patients carrying the E326K and T369M GBA risk variants

Tatiana Usnich, Maria Olmedillas, Nathalie Schell, Jefri J. Paul, Filipa Curado, Snezana Skobalj, Ilona Csoti, Sibel Ertan, Doreen Gruber, Simone Zittel, Esther Sammler, Stuart H. Isaacson, Andrea A. Kuehn, David J. Pedrosa, Kathrin Reetz, Meike Kasten, Arndt Rolfs, Peter Bauer, Volha Skrahina, Christine Klein, Norbert Brueggemann

PARKINSONISM & RELATED DISORDERS (2023)

Add to Collection

Article Clinical Neurology

A KMT2B Frameshift Variant Causing Focal Dystonia Restricted to the Oromandibular Region After Long-Term Follow-up

Alfand Marl F. Dy Closas, Katja Lohmann, Ai Huey Tan, Norlinah Mohamed Ibrahim, Jia Lun Lim, Yi Wen Tay, Kalai Arasu Muthusamy, Azlina Binti Ahmad-Annuar, Christine Klein, Shen -Yang Lim

Summary: KMT2B-linked dystonia (DYT-KMT2B) is a childhood-onset dystonia syndrome that commonly progresses from the lower limbs to the upper limbs and eventually affects the craniocervical region. It is now recognized as one of the more common monogenic causes of dystonia syndromes. This report presents an atypical case of DYT-KMT2B with oromandibular dystonia as the initial symptom, which remained localized to this region for three decades. This is the first reported case of DYT-KMT2B from Southeast Asia and provides further evidence for the pathogenic impact of the KMT2B c.6210_6213delTGAG variant.

JOURNAL OF MOVEMENT DISORDERS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Role of Ceramides and Sphingolipids in Parkinson's Disease

Melissa Vos, Christine Klein, Andrew A. Hicks

Summary: Sphingolipids, a subset of bioactive lipids, play a crucial role in proper neuronal function and are involved in almost all biological processes. Recent studies have found alterations in sphingolipids in patients with Parkinson's disease (PD), suggesting an important interaction between sphingolipids and PD-related cellular processes. This article discusses the role of sphingolipids in mitochondrial dysfunction, autophagy defects, and abnormal endosomal activity in PD.

JOURNAL OF MOLECULAR BIOLOGY (2023)

Add to Collection

Letter Clinical Neurology

The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity

Max Borsche, Neringa Pratuseviciute, Susen Schaake, Frauke Hinrichs, Gabriel Morel, Jan Uter, Katja Lohmann, Christine Klein, Dario R. Alessi, Johann Hagenah, Esther Sammler

MOVEMENT DISORDERS (2023)

Add to Collection

Article Clinical Neurology

Tremor is associated with familial clustering of dystonia

Sebastian Loens, Feline Hamami, Katja Lohmann, Thorsten Odorfer, Chi Wang Ip, Simone Zittel, Kirsten E. Zeuner, Judith Everding, Jos Becktepe, Katrin Marth, Friederike Borngraeber, Katja Kollewe, Christoph Kamm, Andrea A. Kuehn, Mathias Gelderblom, Jens Volkmann, Christine Klein, Tobias Baeumer

Summary: This study aims to identify clinical and demographic features associated with heritability of yet idiopathic dystonia. Tremor is associated with an increased risk of familial clustering of dystonia and with a family history of tremor itself. This indicates a hereditable dystonia-tremor syndrome with a clinical spectrum ranging from tremor-predominant diseases to dystonia.

PARKINSONISM & RELATED DISORDERS (2023)

Add to Collection

Article Cell & Tissue Engineering

p Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson?s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p. T610A) in the RHOT1 gene encoding Miro1

Axel Chemla, Giuseppe Arena, Claudia Saraiva, Clara Berenguer-Escuder, Dajana Grossmann, Anne Grunewald, Christine Klein, Philip Seibler, Jens C. Schwamborn, Rejko Kruger

Summary: In this study, two Parkinson's disease patients' primary skin fibroblasts carrying distinct heterozygous mutations in the RHOT1 gene encoding Miro1 were reprogrammed into induced pluripotent stem cells (iPSCs) using episomal reprogramming. Isogenic gene-corrected lines were generated using CRISPR/Cas9 technology. Both isogenic pairs were comprehensively characterized and quality assured to study the Miro1-related molecular mechanisms underlying neurodegeneration in iPSC-derived neuronal models.

STEM CELL RESEARCH (2023)

Add to Collection

Article Neurosciences

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers

Maria Paulina Castelo Rueda, Alessandra Zanon, Valentina Gilmozzi, Alexandros A. Lavdas, Athina Raftopoulou, Sylvie Delcambre, Fabiola Del Greco, Christine Klein, Anne Gruenewald, Peter P. Pramstaller, Andrew A. Hicks, Irene Pichler

Summary: Homozygous or compound heterozygous variants in PRKN are causal for PD with highly penetrant symptom expression, while heterozygous variants may predispose to PD with reduced penetrance, through altered mitochondrial function. We generated lymphoblasts and hiPSC-derived neurons from non-manifesting heterozygous PRKN variant carriers and tested them for mitochondrial functionality. We identified molecular phenotypes that might be used to monitor heterozygous PRKN variant carriers during the prodromal phase and to test potential neuroprotective therapies.

NPJ PARKINSONS DISEASE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.